Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6GDM

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-X
Temperature [K]100
Detector technologyCCD
Collection date2013-04-10
DetectorRIGAKU SATURN 944+
Wavelength(s)1.54178
Spacegroup nameP 1 21 1
Unit cell lengths48.722, 70.690, 60.615
Unit cell angles90.00, 109.45, 90.00
Refinement procedure
Resolution27.470 - 1.910
R-factor0.18515
Rwork0.182
R-free0.24265
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.010
RMSD bond angle1.427
Data reduction softwareXDS
Data scaling softwareSCALA
Phasing softwareREFMAC
Refinement softwareREFMAC (5.8.0222)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]57.1561.970
High resolution limit [Å]1.9101.910
Rmeas0.0510.483
Number of reflections30330689
<I/σ(I)>141.9
Completeness [%]97.783.6
Redundancy2.7
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.229335.0%w/v MPEG 2000, 0.2M (NH4)2SO4, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol

224931

PDB entries from 2024-09-11

PDB statisticsPDBj update infoContact PDBjnumon